Survival analysis, with respect to gene expression, after age and tumor stage adjustments, revealed that high FOXM1 expression was associated with a poor ESCC patients prognosis, presenting a 2.73-fold increase of the risk of death (p = 0.03; 95% CI 1.11-5.93). The gene discussed is FOXM1; the disease is esophageal squamous cell carcinoma.